Cargando…
Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study
At present, it has been noticed that some patients recovered from COVID-19 present a recurrent positive RNA test of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) after being discharged from hospitals. The purpose of the current study was to characterize the clinical features of re-hos...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808928/ https://www.ncbi.nlm.nih.gov/pubmed/33447913 http://dx.doi.org/10.1007/s10096-020-04151-9 |
_version_ | 1783637007231090688 |
---|---|
author | Pan, Lei Wang, Runsheng Yu, Na Hu, Chao Yan, Junhong Zhang, Xiaomin Wang, Tao Hao, Jungui Gao, Fuquan Liu, Tonggang Wang, Jing Liu, Xiaojing Mu, Mi Huang, Wei Guo, Yongzhong Lv, Changjun Wang, Xiaozhi Tu, Lei Wan, Kun Xu, Guogang |
author_facet | Pan, Lei Wang, Runsheng Yu, Na Hu, Chao Yan, Junhong Zhang, Xiaomin Wang, Tao Hao, Jungui Gao, Fuquan Liu, Tonggang Wang, Jing Liu, Xiaojing Mu, Mi Huang, Wei Guo, Yongzhong Lv, Changjun Wang, Xiaozhi Tu, Lei Wan, Kun Xu, Guogang |
author_sort | Pan, Lei |
collection | PubMed |
description | At present, it has been noticed that some patients recovered from COVID-19 present a recurrent positive RNA test of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) after being discharged from hospitals. The purpose of the current study was to characterize the clinical features of re-hospitalized patients with recurrent SARS-CoV-2 positive results. From January 12 to April 1 of 2020, our retrospective study was conducted in China. The exposure history, baseline data, laboratory findings, therapeutic schedule, and clinical endpoints of the patients were collected. All the patients were followed until April 10, 2020. Among all COVID-19 patients included in the current study, there were 14 re-hospitalized patients due to recurrent positive tests of SARS-CoV-2 RNA. Fever (11 [78.6%]), cough (10 [71.4%]), and fatigue (7 [50.0%]) were the most common symptoms on the patient’s first admission, and less symptoms were found on their second admission. The average duration from the onset of symptoms to admission to hospital was found to be 8.4 days for the first admission and 2.6 days for the second admission (P = 0.002). The average time from the detection of RNA (+) to hospitalization was 1.9 days for the first admission and 2.6 days for the second admission (P = 0.479), and the average time from RNA (+) to RNA (−) was 11.1 days for the first admission and 6.3 days for the second admission (P = 0.030). Moreover, the total time in hospital was 18.6 days for the first admission and 8.0 days for the second admission (P = 0.000). It may be necessary to increase the isolation observation time and RT-PCR tests should be timely performed on multiple samples as soon as possible. |
format | Online Article Text |
id | pubmed-7808928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-78089282021-01-15 Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study Pan, Lei Wang, Runsheng Yu, Na Hu, Chao Yan, Junhong Zhang, Xiaomin Wang, Tao Hao, Jungui Gao, Fuquan Liu, Tonggang Wang, Jing Liu, Xiaojing Mu, Mi Huang, Wei Guo, Yongzhong Lv, Changjun Wang, Xiaozhi Tu, Lei Wan, Kun Xu, Guogang Eur J Clin Microbiol Infect Dis Original Article At present, it has been noticed that some patients recovered from COVID-19 present a recurrent positive RNA test of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) after being discharged from hospitals. The purpose of the current study was to characterize the clinical features of re-hospitalized patients with recurrent SARS-CoV-2 positive results. From January 12 to April 1 of 2020, our retrospective study was conducted in China. The exposure history, baseline data, laboratory findings, therapeutic schedule, and clinical endpoints of the patients were collected. All the patients were followed until April 10, 2020. Among all COVID-19 patients included in the current study, there were 14 re-hospitalized patients due to recurrent positive tests of SARS-CoV-2 RNA. Fever (11 [78.6%]), cough (10 [71.4%]), and fatigue (7 [50.0%]) were the most common symptoms on the patient’s first admission, and less symptoms were found on their second admission. The average duration from the onset of symptoms to admission to hospital was found to be 8.4 days for the first admission and 2.6 days for the second admission (P = 0.002). The average time from the detection of RNA (+) to hospitalization was 1.9 days for the first admission and 2.6 days for the second admission (P = 0.479), and the average time from RNA (+) to RNA (−) was 11.1 days for the first admission and 6.3 days for the second admission (P = 0.030). Moreover, the total time in hospital was 18.6 days for the first admission and 8.0 days for the second admission (P = 0.000). It may be necessary to increase the isolation observation time and RT-PCR tests should be timely performed on multiple samples as soon as possible. Springer Berlin Heidelberg 2021-01-15 2021 /pmc/articles/PMC7808928/ /pubmed/33447913 http://dx.doi.org/10.1007/s10096-020-04151-9 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Pan, Lei Wang, Runsheng Yu, Na Hu, Chao Yan, Junhong Zhang, Xiaomin Wang, Tao Hao, Jungui Gao, Fuquan Liu, Tonggang Wang, Jing Liu, Xiaojing Mu, Mi Huang, Wei Guo, Yongzhong Lv, Changjun Wang, Xiaozhi Tu, Lei Wan, Kun Xu, Guogang Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study |
title | Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study |
title_full | Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study |
title_fullStr | Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study |
title_full_unstemmed | Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study |
title_short | Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study |
title_sort | clinical characteristics of re-hospitalized covid-19 patients with recurrent positive sars-cov-2 rna: a retrospective study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808928/ https://www.ncbi.nlm.nih.gov/pubmed/33447913 http://dx.doi.org/10.1007/s10096-020-04151-9 |
work_keys_str_mv | AT panlei clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT wangrunsheng clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT yuna clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT huchao clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT yanjunhong clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT zhangxiaomin clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT wangtao clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT haojungui clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT gaofuquan clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT liutonggang clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT wangjing clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT liuxiaojing clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT mumi clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT huangwei clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT guoyongzhong clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT lvchangjun clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT wangxiaozhi clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT tulei clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT wankun clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy AT xuguogang clinicalcharacteristicsofrehospitalizedcovid19patientswithrecurrentpositivesarscov2rnaaretrospectivestudy |